Skip to main content

2 Result(s)

within Claudia Tandler Remove this filter Oncology Remove this filter

and

  1. Article

    Open Access

    BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic efficacy of blinatumomab in vitro

    Acute B-lymphoblastic leukemia (B-ALL) is a malignant disease characterized by accumulation of clonal immature lymphocytes in the bone marrow and peripheral blood. The approval of BCR::ABL1 tyrosine kinase inh...

    Joseph Kauer, Melanie Märklin… in Journal of Cancer Research and Clinical On… (2022)

    Download PDF (1655 KB) View Article

  2. Article

    Open Access

    Identification of CD105 (endoglin) as novel risk marker in CLL

    Several genetic and clinical markers are established as prognostic factors in chronic lymphocytic leukemia (CLL). However, additional markers are needed for risk stratification. Flow cytometric analysis is a m...

    Sarah M. Greiner, Melanie Märklin, Samuel Holzmayer, Kübra Kaban… in Annals of Hematology (2022)

    Download PDF (864 KB) View Article